Hisao Kawasaki
Vendite & Marketing presso Quantum Biosystems, Inc.
Provenienza dei contatti di primo grado di Hisao Kawasaki
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Quantum Biosystems, Inc.
Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan.
6
| Holding Company | Biotechnology | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Hisao Kawasaki tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ORACLE CORPORATION | Packaged Software | Corporate Officer/Principal | |
HOSOKAWA MICRON CORPORATION | Industrial Machinery | Corporate Officer/Principal | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Tokyo | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
MICROWAVE CHEMICAL CO., LTD. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
University of Michigan | College/University | Graduate Degree | |
GORYO Chemical, Inc.
GORYO Chemical, Inc. Chemicals: Major DiversifiedProcess Industries GORYO Chemical, Inc. develops and sells fluorescent probes. It offers Fluorescence imaging, Cancer Targets, in vitro cellular assay, in vivo imaging, cell, Super-Resolution Microscopy, Optical Microscopy, Small Animal Molecular Imaging, Near Infrared Fluorescence, High Content Screening, Molecular Biology and Molecular Diagnostics. The company was founded on July 16, 2010 by Ken-ichi Maruyama and is headquartered in Sapporo, Japan. | Chemicals: Major Diversified | Director of Finance/CFO | |
McKinsey & Co. (Japan) | Corporate Officer/Principal | ||
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
JAFCO GROUP CO., LTD. | Investment Managers | Corporate Officer/Principal | |
Veolia Japan KK
Veolia Japan KK Water UtilitiesUtilities Veolia Japan KK engages in the provision of water, energy and materials solutions focusing on waste receovery. Its services include operation and maintenance of water and wastewater treatment facilities; design, construction, and management of water and wastewater treatment facilities; pipe network management; platic recycling and renewable energy. The company was founded on May 1, 2002 and is headquartered in Tokyo, Japan. | Water Utilities | Corporate Officer/Principal | |
Keio University | College/University | Graduate Degree | |
CYFUSE BIOMEDICAL K.K. | Biotechnology | Director/Board Member | |
RIVERFIELD, Inc.
RIVERFIELD, Inc. Medical SpecialtiesHealth Technology RIVERFIELD, Inc. engages in the research, development, and manufacture of medical equipment systems. It specializes in the production and commercialization of surgical robotic support systems for the medical and healthcare industries. The firm also offers endoscopic operation systems. The company was founded on May 20, 2014 and is headquartered in Tokyo, Japan. | Medical Specialties | Director/Board Member | |
Beyond Next Ventures, Inc.
Beyond Next Ventures, Inc. Investment ManagersFinance Beyond Next Ventures, Inc. (Beyond Next Ventures) is an Independent Venture Capital firm founded in 2014. Beyond Next Ventures, Inc. is headquartered in Tokyo. | Investment Managers | Private Equity Investor | |
Megakaryon Corp.
Megakaryon Corp. Medical/Nursing ServicesHealth Services Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan. | Medical/Nursing Services | Director/Board Member | |
GLOBIS University | College/University | Masters Business Admin | |
Anaeropharma Science, Inc.
Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member | |
Osaka University | College/University | Doctorate Degree | |
The University of Southampton | College/University | Undergraduate Degree | |
GN Hearing A/S
GN Hearing A/S Medical SpecialtiesHealth Technology GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark. | Medical Specialties | Corporate Officer/Principal | |
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | Investment Managers | Private Equity Investor | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
Molcure, Inc.
Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member | |
Provigate KK
Provigate KK Medical SpecialtiesHealth Technology Provigate KK engages in the development, manufacture and sale of blood glucose level measuring instrument. The company was founded in March 2015 and is headquartered in Tokyo, Japan. | Medical Specialties | Director/Board Member | |
Elixirgen Therapeutics, Inc.
Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD. | Pharmaceuticals: Major | Director/Board Member | |
Adacotech, Inc.
Adacotech, Inc. Aerospace & DefenseElectronic Technology Adacotech, Inc. is a Japanese company that specializes in the research, development, manufacture, and sales of systems related to video surveillance and automatic recognition. The company is based in Tokyo, Japan. The company was founded in 2012. Ryota Kawamura has been the CEO of the company since 2019. | Aerospace & Defense | Director/Board Member | |
NANO MRNA CO.,LTD. | Pharmaceuticals: Other | Director of Finance/CFO | |
ANGES, INC. | Pharmaceuticals: Generic | Director of Finance/CFO | |
SCOHIA PHARMA, Inc.
SCOHIA PHARMA, Inc. Miscellaneous Commercial ServicesCommercial Services SCOHIA PHARMA, Inc. is a drug discovery venture that focuses on lifestyle-related diseases. The company is based in Fujisawa, Japan. The Japanese company has a strong development pipeline and an experienced R & D team that specializes in drug discovery, including compound creation, drug efficacy evaluation, and clinical development. The CEO of the company is Masanori Watanabe. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
Giappone | 23 |
Stati Uniti | 9 |
Regno Unito | 2 |
Danimarca | 2 |
Settori
Health Technology | 10 |
Consumer Services | 10 |
Commercial Services | 4 |
Finance | 4 |
Technology Services | 2 |
Posizioni
Director/Board Member | 18 |
Corporate Officer/Principal | 9 |
Director of Finance/CFO | 8 |
Masters Business Admin | 4 |
Graduate Degree | 4 |
Contatti più connessi
- Borsa valori
- Insiders
- Hisao Kawasaki
- Connessioni Società